Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYL for Mild to Moderate Alzheimer's Disease

BusinesswireAug 19 08:30 ET

Express News | Alpha Cognition Inc - Received Indications of Interest From Parties Wanting to Provide Bridge Funding

ReutersAug 13 17:02 ET

Express News | Alpha Cognition Inc - Has Chosen to Explore Alternative Strategies

ReutersAug 13 17:02 ET

Express News | Alpha Cognition Inc - Decision to Temporarily Delay Its Planned Capital Raise and Uplisting to Nasdaq Capital Market

ReutersAug 13 17:02 ET

Alpha Cognition, Inc. On Track to Secure Financing for Continued Growth

BusinesswireAug 13 17:02 ET

Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update

BusinesswireAug 12 16:35 ET